[Federal Register Volume 66, Number 43 (Monday, March 5, 2001)]
[Notices]
[Pages 13331-13332]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-5224]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Proposed Collection: 
Comment Request

    In compliance with the requirement for opportunity for public 
comment on proposed data collection projects (section 3506(c)(2)(A) of 
Title 44, United States Code, as amended by the Paperwork Reduction Act 
of 1995, Public Law 104-13), the Health Resources and Services 
Administration (HRSA) publishes periodic summaries of proposed projects 
being developed for submission to OMB under the Paperwork Reduction Act 
of 1995. To request more information on the proposed project or to 
obtain a copy of the data collection plans and draft instruments, call 
the HRSA Reports Clearance Officer on (301) 443-1129.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Proposed Project

Clinical Pharmacy Demonstration Project Evaluation: NEW

    The Clinical Pharmacy Demonstration Projects, a supplemental grant 
opportunity for health center networks, were established to evaluate 
the impact of comprehensive pharmacy services on the patients served by 
Health Resources and Services Administration (HRSA) supported programs. 
The overarching mission is to demonstrate the effect of implementing 
comprehensive pharmacy services in underserved populations. By 
collecting data regarding health outcomes and the level of pharmacy 
services provided, the Office of Pharmacy Affairs hopes to establish 
the provision of comprehensive pharmacy services as a key to improving 
access and eliminating health disparities.
    The grantee networks will provide valuable pharmacy services to 
patients, and in the process generate data that will demonstrate the 
effect of the projects on health outcomes. Patient encounter data will 
be collected (baseline and semi-annual) for diabetic patients who 
receive clinical pharmacy services. In addition, each participating 
pharmacy will complete survey instruments (baseline, annual) for 
utilization, financial, and process data which describe the program. 
These data will result in the following: the creation of a database to 
document the nationwide impact of implementing comprehensive pharmacy 
services through the Clinical Pharmacy Demonstration Projects in 
underserved areas; and, information sources for the sharing of best 
practices, with the ultimate goal of aiding other health

[[Page 13332]]

center networks in the implementation of comprehensive pharmacy 
services.
    The estimated burden is as follows:

----------------------------------------------------------------------------------------------------------------
                                                                            Responses                   Total
                          Form name                            Number of       per       Hours per      burden
                                                              respondents   respondent    response      hours
----------------------------------------------------------------------------------------------------------------
Baseline....................................................         1400            1          .33          462
Encounter data..............................................         1400            4          .16          933
Pharmacy Survey.............................................           14            3            1           42
                                                             ---------------------------------------------------
    Total...................................................         1414  ...........  ...........         1437
----------------------------------------------------------------------------------------------------------------

    Send comments to Susan G. Queen, Ph.D., HRSA Reports Clearance 
Officer, Room 14-22, Parklawn Building, 5600 Fishers Lane, Rockville, 
MD 20857. Written comments should be received within 60 days of this 
---------------------------------------------------------------------------
notice.

    Dated: February 27, 2001.
Jane M. Harrison,
Director, Division of Policy Review and Coordination.
[FR Doc. 01-5224 Filed 3-2-01; 8:45 am]
BILLING CODE 4160-15-P